Aion Therapeutic (XCNQ:AION) Change In Receivables : C$0.11 Mil (TTM As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Aion Therapeutic Change In Receivables?

Aion Therapeutic's change in receivables for the quarter that ended in Jan. 2024 was C$-0.04 Mil. It means Aion Therapeutic's Accounts Receivable increased by C$0.04 Mil from Oct. 2023 to Jan. 2024 .

Aion Therapeutic's change in receivables for the fiscal year that ended in Apr. 2023 was C$-0.06 Mil. It means Aion Therapeutic's Accounts Receivable increased by C$0.06 Mil from Apr. 2022 to Apr. 2023 .

Aion Therapeutic's Accounts Receivable for the quarter that ended in Jan. 2024 was C$0.06 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Aion Therapeutic's Days Sales Outstanding for the three months ended in Jan. 2024 was 24.25.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Aion Therapeutic's liquidation value for the three months ended in Jan. 2024 was C$-4.26 Mil.

Aion Therapeutic Change In Receivables Historical Data

The historical data trend for Aion Therapeutic's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic Change In Receivables Chart

Aion Therapeutic Annual Data

Trend

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Change In Receivables

Get a 7-Day Free Trial

-0.20

0.25

-0.08

-0.06

Aion Therapeutic Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Change In Receivables	Get a 7-Day Free Trial															-0.01	-0.02	0.16	0.02	-0.04

Aion Therapeutic Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.11 Mil.

Aion Therapeutic (XCNQ:AION) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Aion Therapeutic's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.059	/	0.222	*	91
=	24.25

2. In Ben Graham's calculation of liquidation value, Aion Therapeutic's accounts receivable are only considered to be worth 75% of book value:

Aion Therapeutic's liquidation value for the quarter that ended in Jan. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.349	-	4.855	+	0.75 * 0.059	+	0.5 * 0.4
=	-4.26

Aion Therapeutic Change In Receivables Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Aion Therapeutic (XCNQ:AION) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (XCNQ:AION) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

ANTCF:USA

Address

700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8

Website

https://www.aiontherapeutic.com

Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.

Executives

Ismail Abdul Fattah

Director or Senior Officer of 10% Security Holder

Aion Therapeutic (XCNQ:AION) Headlines

No Headlines